Us Bancorp \De\ Axogen, Inc. Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.53 - $10.95 $783 - $1,138	104 Added 10.07%	1,137 $10,000
Q2 2022 Aug 01, 2022	BUY	$6.99 - $10.0 $230 - $330	33 Added 3.3%	1,033 $8,000
Q1 2022 May 11, 2022	SELL	$7.26 - $10.7 $22,295 - $32,859	-3,071 Reduced 75.44%	1,000 $8,000
Q4 2021 Feb 11, 2022	BUY	$8.8 - $16.0 $27,024 - $49,136	3,071 Added 307.1%	4,071 $38,000
Q3 2021 Nov 10, 2021	SELL	$15.23 - $21.72 $654 - $933	-43 Reduced 4.12%	1,000 $16,000
Q2 2021 Aug 05, 2021	BUY	$17.8 - $23.5 $17,800 - $23,500	1,000 Added 2325.58%	1,043 $23,000
Q1 2021 Apr 28, 2021	BUY	$17.18 - $22.6 $738 - $971	43 New	43 $1,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.